心臓再同期療法除細動器(CRT-D) の世界市場2016-2020

◆英語タイトル:Global Cardiac Resynchronization Therapy Defibrillator Market 2016-2020
◆商品コード:IRTNTR9455
◆発行会社(調査会社):Technavio
◆発行日:2016年6月7日
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、心臓再同期療法除細動器(CRT-D) の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、心臓再同期療法除細動器(CRT-D) の世界市場規模及び予測、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、コスト分析、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About the Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market
Heart failure, a condition when the heart cannot pump enough blood to meet the body’s need, is one of the leading causes of death. Heart failure and stroke, if occurred together, can lead to major health problems or cause sudden death.
Irregularity in ventricular rate can lead to reduction of diastolic dysfunction, a condition when there is abnormality in how the heart fills with blood causing pressure in the pulmonary vessel, leading to AF. Hence, patients with high risk of AF use CRT-D devices to minimize the risk associated with irregular heartbeat. The use of CRT-D devices enhances the functioning of the heart’s electrical activity and improves heart rhythm. These devices are small in size and are placed below the collar bone.

Technavio’s analysts forecast the global cardiac resynchronization therapy defibrillator (CRT-D) market to grow at a CAGR of 8.36% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy defibrillator (CRT-D) market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of CRT-D devices.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Boston Scientific
• Medtronic
• St. Jude Medical
• LivaNova

[Other prominent vendors]
• BIOTRONIK
• Cook Medical
• Spectranetics

[Market driver]
• Clinical considerations
• For a full, detailed list, view our report

[Market challenge]
• High cost
• For a full, detailed list, view our report

[Market trend]
• Growing popularity of robotic-assistance surgery
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Cost analysis of CRT-D device implantation

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Geographical segmentation
• CRT-D market in Americas
• CRT-D market in EMEA
• CRT-D market in APAC

PART 08: Market drivers
• Increased incidence of cardiac disorders
• Increasing regulatory approvals
• Clinical considerations
• Increased public awareness

PART 09: Impact of drivers

PART 10: Market challenges
• High cost
• Popularity of alternative devices
• Complications associated with CRT-D devices

PART 11: Impact of drivers and challenges

PART 12: Market trends
• Increased use of MRI in clinical applications
• Focus on R&D
• Growing popularity of robotic-assistance surgery

PART 13: Vendor landscape
• Competitive scenario
• Market share analysis
• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

PART 15: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Cost comparison of CRT-D and ICD system implantation
Exhibit 03: Cost difference of system implantation and medical services in CRT-D 2015
Exhibit 04: Cost difference of system implantation and medical services in ICD 2015
Exhibit 05: Cost breakdown of system components in CRT-D implantation 2015
Exhibit 06: Cost breakdown of system components in ICD implantation 2015
Exhibit 07: Cost breakdown of medical services in CRT-D implantation 2015
Exhibit 08: Cost breakdown of medical services in ICD implantation 2015
Exhibit 09: Global CRT-D market 2015-2020 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Global CRT-D market by geography 2015
Exhibit 12: Global CRT-D market by geography 2020
Exhibit 13: Global CRT-D market by geography 2015-2020 ($ millions)
Exhibit 14: Global CRT-D market by geography 2015-2020 (%)
Exhibit 15: CRT-D market in Americas 2015-2020 ($ billions)
Exhibit 16: Prevalence of AF in few European countries 2014 (%)
Exhibit 17: CRT-D market in EMEA 2015-2020 ($ millions)
Exhibit 18: CRT-D market in APAC 2015-2020 ($ millions)
Exhibit 19: Impact of drivers
Exhibit 20: Impact of drivers and challenges
Exhibit 21: Top vendors in global CRT-D market 2015
Exhibit 22: Boston Scientific: Cardiac rhythm management segmentation by revenue 2014
Exhibit 23: Boston Scientific: Cardiac rhythm management segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 24: Boston Scientific: Cardiac rhythm management geographical segmentation by revenue 2014
Exhibit 25: Boston Scientific: Key takeaways
Exhibit 26: LivaNova: Cardiac rhythm management segmentation by revenue 2014
Exhibit 27: LivaNova: Cardiac rhythm management segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 28: LivaNova: Key takeaways
Exhibit 29: Medtronic: Key takeaways
Exhibit 30: St. Jude Medical: Key takeaways



【掲載企業】

Boston Scientific, LivaNova, Medtronic, St. Jude Medical, BIOTRONIK, Cook Medical, Spectranetics.

【レポートのキーワード】

心臓再同期療法(CRT)、除細動器、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[心臓再同期療法除細動器(CRT-D) の世界市場2016-2020]販売に関する免責事項
★調査レポート[心臓再同期療法除細動器(CRT-D) の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆